Sale!

COL12A1 Gene Bethlem Myopathy Type 2 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The COL12A1 Gene Bethlem Myopathy Type 2 NGS Genetic DNA Test is a comprehensive genetic analysis designed to detect mutations in the COL12A1 gene associated with Bethlem myopathy type 2, a rare inherited neuromuscular disorder. This advanced next-generation sequencing test provides precise identification of genetic variants that cause progressive muscle weakness, joint contractures, and connective tissue abnormalities. The test is particularly valuable for individuals experiencing unexplained muscle weakness, delayed motor milestones, or those with a family history of neuromuscular conditions. Results from this $500 USD test enable accurate diagnosis, guide treatment decisions, and provide crucial information for family planning. Our state-of-the-art NGS technology ensures high accuracy and comprehensive coverage of the COL12A1 gene, making it an essential tool for neurologists and genetic specialists.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

COL12A1 Gene Bethlem Myopathy Type 2 NGS Genetic DNA Test

Comprehensive Genetic Testing for Neuromuscular Disorders

The COL12A1 Gene Bethlem Myopathy Type 2 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations responsible for Bethlem myopathy type 2, a rare inherited neuromuscular condition. This sophisticated genetic analysis utilizes next-generation sequencing technology to provide comprehensive evaluation of the COL12A1 gene, which encodes collagen type XII alpha 1 chain—a crucial component of the extracellular matrix in muscle tissue.

What This Test Measures and Detects

This advanced genetic test specifically targets the COL12A1 gene to identify pathogenic variants associated with Bethlem myopathy type 2. The test examines:

  • Point mutations, insertions, and deletions in the COL12A1 gene
  • Variants affecting collagen XII production and function
  • Genetic changes that disrupt extracellular matrix integrity
  • Inheritance patterns and familial risk assessment

Using state-of-the-art NGS technology, the test provides comprehensive coverage of the entire COL12A1 gene, ensuring high sensitivity and specificity in detecting clinically relevant mutations.

Who Should Consider This Test

This genetic test is recommended for individuals experiencing:

  • Progressive muscle weakness beginning in childhood or early adulthood
  • Joint contractures affecting fingers, elbows, and ankles
  • Delayed motor milestones in childhood
  • Family history of neuromuscular disorders
  • Unexplained connective tissue abnormalities
  • Diagnostic uncertainty in cases of suspected muscular dystrophy

Clinical Benefits of Genetic Testing

Undergoing the COL12A1 Gene Bethlem Myopathy Type 2 NGS Genetic DNA Test provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms or rules out Bethlem myopathy type 2 with high precision
  • Personalized Treatment Planning: Guides appropriate management strategies based on genetic findings
  • Family Risk Assessment: Identifies inheritance patterns and assesses risk for family members
  • Reproductive Planning: Provides crucial information for family planning decisions
  • Prognostic Information: Helps predict disease progression and potential complications
  • Research Contribution: Contributes to ongoing research and understanding of rare neuromuscular disorders

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and neurologists. Results typically fall into one of these categories:

  • Positive Result: Identifies a pathogenic variant in the COL12A1 gene, confirming Bethlem myopathy type 2 diagnosis
  • Negative Result: No pathogenic variants detected, though this doesn’t completely rule out the condition in all cases
  • Variant of Uncertain Significance: Identifies a genetic change whose clinical significance is currently unknown
  • Carrier Status: Identifies individuals who carry one copy of a mutated gene but may not show symptoms

Our genetic counseling team will provide comprehensive explanation of your results and discuss implications for your health management and family planning.

Test Pricing Information

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We proudly offer the COL12A1 Gene Bethlem Myopathy Type 2 NGS Genetic DNA Test across the United States through our extensive network of testing facilities. Our services are available in all major metropolitan areas including:

  • New York City and surrounding regions
  • Los Angeles and Southern California
  • Chicago and the Midwest
  • Houston and Texas metropolitan areas
  • Phoenix and Arizona regions
  • Philadelphia and the Northeast corridor

With convenient locations nationwide, accessing advanced genetic testing has never been easier. Our facilities maintain the highest standards of laboratory excellence and patient care.

Take Control of Your Neurological Health

Don’t let uncertainty about neuromuscular symptoms affect your quality of life. The COL12A1 Gene Bethlem Myopathy Type 2 NGS Genetic DNA Test provides the clarity needed for informed healthcare decisions. Our team of genetic specialists and neurologists is ready to support you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward understanding your genetic health.

Early diagnosis through genetic testing can significantly impact treatment outcomes and quality of life. Trust our expertise in neurological genetics to provide the answers you need for better health management.